| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 44 | 21359 | SH | DFND | 1 | 21359 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 42 | 20306 | SH | DFND | 20306 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 56 | 27499 | SH | DFND | 1 | 0 | 0 | 27499 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 0 | 122 | SH | DFND | 30 | 0 | 122 | 0 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000919574-22-003439 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | TWO SIGMA INVESTMENTS, LP | 1179392 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 221 | 107747 | SH | SOLE | 107747 | 0 | 0 | May 17th, 2022 01:34AM | May 17th, 2022 01:34AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000919574-22-003430 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | TWO SIGMA ADVISERS, LP | 1478735 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 290 | 141600 | SH | SOLE | 137100 | 0 | 4500 | May 17th, 2022 01:34AM | May 17th, 2022 01:34AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000769993-22-000283 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | GOLDMAN SACHS GROUP INC | 886982 | ZYNERBA PHARMACEUTICALS INC | CMN | 98986X109 | 45 | 21726 | SH | DFND | 2 | 21726 | 0 | 0 | May 17th, 2022 01:29AM | May 17th, 2022 01:29AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000093751-22-000509 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | STATE STREET CORP | 93751 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 245 | 119741 | SH | DFND | 20 | 119741 | 0 | 0 | May 17th, 2022 01:26AM | May 17th, 2022 01:26AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000080255-22-002340 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | PRICE T ROWE ASSOCIATES INC /MD/ | 80255 | ZYNERBA PHARMACEUTICALS INC | COMM STK | 98986X109 | 37 | 18200 | SH | SOLE | 18200 | 0 | 0 | May 17th, 2022 01:26AM | May 17th, 2022 01:26AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:zyne | nasdaq:zyne Shareholders | 13F-HR | 0000072971-22-000135 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WELLS FARGO & COMPANY/MN | 72971 | ZYNERBA PHARMACEUTICALS INC | COM | 98986X109 | 4 | 1750 | SH | DFND | 15 | 0 | 0 | 1750 | May 17th, 2022 01:25AM | May 17th, 2022 01:25AM | Zynerba Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |